- NEWS
Potent new pill provides COVID relief for the masses
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 625, 644 (2024)
doi: https://doi.org/10.1038/d41586-024-00117-5
References
Cao, B. et al. N. Eng. J. Med. 390, 230–241 (2024).
Why scientists are racing to develop more COVID antivirals
African clinical trial denied access to key COVID drug Paxlovid
COVID drug drives viral mutations — and now some want to halt its use
COVID drug Paxlovid was hailed as a game-changer. What happened?
New COVID drugs face delays as trials grow more difficult
COVID rebound is surprisingly common — even without Paxlovid
New pill helps COVID smell and taste loss fade quickly